Valeant’s One-Two Punch Sends Allergan Ducking And Weaving; Who’s Next In The Ring?

Valeant’s partnership with activist investor William Ackman to acquire Allergan for around $46 billion would be Valeant’s largest acquisition but sets the stage for a protracted fight.